Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5

To report vision and safety outcomes from an extension of a 2-year investigation evaluating verteporfin photodynamic therapy in patients with age-related macular degeneration with subfoveal choroidal neovascularization (CNV).


Published in:
Archives of ophthalmology, 120, 10, 1307-1314
Year:
2002
Publisher:
American Medical Association
ISSN:
0003-9950
Keywords:
Note:
Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group
Laboratories:




 Record created 2011-02-01, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)